The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast .

Studying dogs and cancer is a way to learn about cancer in people. It’s not that dogs and owners share exposures to ...

The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...

The renowned research hospital that cares for people with rare or life-threatening diseases has been pummeled by an employee ...